Tuesday, 23 October 2018
Latest news
Main » Decatur Capital Management Inc. Raises Stake in Bristol-Myers Squibb Co (BMY)

Decatur Capital Management Inc. Raises Stake in Bristol-Myers Squibb Co (BMY)

13 January 2018

Ameriprise Financial Inc. now owns 15,547,051 shares of the biopharmaceutical company's stock valued at $845,504,000 after buying an additional 2,451,390 shares in the last quarter. Centerbridge Partners Lp who had been investing in Ambac Finl Group Inc for a number of months, seems to be bullish on the $724.47M market cap company. The stock increased 0.53% or $1.02 during the last trading session, reaching $195.2.

Citigroup Inc. (C) exchanged hands at an unexpectedly low level of 13.85 million shares over the course of the day. BP p.l.c. (NYSE:BP) has risen 15.51% since January 10, 2017 and is uptrending. It has underperformed by 14.02% the S&P500.

West Oak Capital Llc increased its stake in Bristol (BMY) by 149.45% based on its latest 2017Q3 regulatory filing with the SEC. Wesbanco Bank Inc owns 231,433 shares or 0.14% of their USA portfolio.

Bristol-Myers Squibb Company (NYSE:BMY) last announced its quarterly earnings data on Thursday, January 26th. The stock decreased 0.49% or $0.3 during the last trading session, reaching $61.55. About 3.40 million shares traded. It has underperformed by 39.89% the S&P500. Tracking most recent quarter period, Price to book (P/B) ration is at 6.86 and Price to cash per share ration is at 14.25. Aperio Grp Inc Lc holds 0.01% or 16,973 shares. Therefore 11% are positive. BP had 52 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned "Overweight" rating on Monday, October 5 by Barclays Capital. The rating was maintained by Cowen & Co with "Hold" on Thursday, August 3. Jefferies upgraded the shares of BMY in report on Monday, December 19 to "Buy" rating. The rating was downgraded by Mainfirst on Wednesday, October 28 to "Underperform". The firm has "Buy" rating given on Wednesday, September 27 by Stifel Nicolaus. On Thursday, June 2 the stock rating was upgraded by JP Morgan to "Neutral". Goldman Sachs Group reaffirmed a buy rating and set a $65.00 price target (up from $62.00) on shares of Bristol-Myers Squibb in a report on Thursday, September 7th. The firm has "Neutral" rating by Credit Suisse given on Friday, October 27.

Since August 16, 2017, it had 0 insider purchases, and 1 insider sale for $83,910 activity.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.01, from 1.26 in 2017Q2. It has no change, as 81 investors sold VZ shares while 696 reduced holdings. only 114 funds opened positions while 570 raised stakes.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. 193.75 million shares or 4.42% more from 185.55 million shares in 2017Q2 were reported. Freestone Capital Hldg Ltd Com stated it has 3,701 shares or 0.02% of all its holdings. Shareholders of record on Friday, January 5th will be paid a $0.40 dividend. Moreover, Dupont Management has 0.04% invested in Realty Income Corporation (NYSE:O) for 28,192 shares. Coldstream Mgmt holds 13,717 shares or 0.1% of its portfolio. Chesley Taft And Llc reported 113,650 shares stake. Barclays Plc owns 599 shares. Crawford Invest Counsel owns 19,994 shares or 0.04% of their U.S. portfolio. Mngmt accumulated 150 shares or 0% of the stock. Howe Rusling reported 0.11% stake. Guardian Cap Advsr L P stated it has 7,700 shares. Proshare Advisors Ltd Liability Corp reported 137,992 shares.

Sessa Capital Im Lp, which manages about $171.01M and $908.16 million US Long portfolio, upped its stake in Versum Matls Inc by 75,000 shares to 1.37 million shares, valued at $53.37 million in 2017Q3, according to the filing. It also reduced Ishares Tr (IWF) stake by 3,652 shares and now owns 2,536 shares.

Bristol-Myers Squibb Company (BMY) stock is now trading 5.98% away from its average-price of 200 days while it maintained a distance of 0.13% from its 50 Days Moving Average and -0.02% compared with the 20 Day Moving Average. Therefore 66% are positive. CF Industries Holdings had 85 analyst reports since July 22, 2015 according to SRatingsIntel. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance. The company was initiated on Wednesday, April 6 by Societe Generale. As per Wednesday, October 18, the company rating was maintained by Citigroup. The firm has a market capitalization of $100,760.00, a PE ratio of 24.28, a price-to-earnings-growth ratio of 2.22 and a beta of 1.18. Bristol-Myers Squibb had a net margin of 20.56% and a return on equity of 32.41%. The Ohio-based Wealthtrust Fairport Limited Liability Company has invested 0.04% in Bristol-Myers Squibb Company (NYSE:BMY). $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Lynch Thomas J. Jr. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has "Buy" rating given on Friday, October 6 by UBS.

Since September 6, 2017, it had 1 buy, and 2 sales for $646,385 activity. Samuels Theodore R. II also bought $249,187 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares. Caldarella Joseph C had sold 9,340 shares worth $560,400.

COPYRIGHT VIOLATION WARNING: "Bristol-Myers Squibb (BMY) Downgraded to Hold at Vetr" was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. They expect $-0.11 EPS, up 71.79% or $0.28 from last year's $-0.39 per share. The institutional investor held 1.44 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $123.65 million, down from 1.44M at the end of the previous reported quarter.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.